InvestSMART

Raptor Metals Ltd (ASX: RAP) - Announcements

Current share price for RAP : $0.030 0.001 (3.23%)+

ASX company news and announcements for Raptor Metals Ltd (RAP) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Raptor Metals Ltd (RAP) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Raptor Metals Ltd (RAP), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Raptor Metals Ltd (RAP)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$12 ResApp Completes Oversubscribed $12.5M Capital Raising 20 Apr 2016 9:04AM $0.245 $0.030 fallen by 87.76%
$12 Trading Halt 18 Apr 2016 9:33AM $0.245 $0.030 fallen by 87.76%
$12 TechKnow Invest Roadshow 2016 Presentation 5 Apr 2016 8:28AM $0.215 $0.030 fallen by 86.05%
$12 ResApp Provides Updated Paediatric Clinical Study Results 31 Mar 2016 10:03AM $0.260 $0.030 fallen by 88.46%
$12 Director Resignation and Appendix 3Z 23 Mar 2016 12:12PM $0.285 $0.030 fallen by 89.47%
$12 Change of Director's Interest Notice 18 Mar 2016 7:42PM $0.270 $0.030 fallen by 88.89%
$12 Response to ASX Aware Query 17 Mar 2016 7:53PM $0.240 $0.030 fallen by 87.50%
$12 ResApp Presentation at the ASX CEO Sessions 15 Mar 2016 9:31AM $0.260 $0.030 fallen by 88.46%
$12 ResApp Completes Successful Pre-Submission Meeting with FDA 14 Mar 2016 9:29AM $0.270 $0.030 fallen by 88.89%
$12 Terms of Executive Appointment 11 Mar 2016 7:02PM $0.270 $0.030 fallen by 88.89%
$12 Response to ASX Price and Volume Query 11 Mar 2016 1:47PM $0.255 $0.030 fallen by 88.24%
$12 ResApp Collaborates with Leading Humanitarian Organisation 7 Mar 2016 8:24AM $0.175 $0.030 fallen by 82.86%
$12 Breakthrough Performance in Paediatric Clinical Study 2 Mar 2016 9:08AM $0.135 $0.030 fallen by 77.78%
$12 Appendix 4D and Half Year Accounts 1 Mar 2016 8:26AM $0.130 $0.030 fallen by 76.92%
$12 Second Site Added to Adult Clinical Study 26 Feb 2016 8:05AM $0.140 $0.030 fallen by 78.57%
$12 Initial Director's Interest Notice 24 Feb 2016 2:40PM $0.140 $0.030 fallen by 78.57%
$12 ResApp Appoints New Director 22 Feb 2016 8:23AM $0.140 $0.030 fallen by 78.57%
$12 Investor Presentation 17 Feb 2016 9:06AM $0.140 $0.030 fallen by 78.57%
$12 Appendix 3B 11 Feb 2016 7:09PM $0.130 $0.030 fallen by 76.92%
$12 Appendix 4C - quarterly 29 Jan 2016 1:26PM $0.135 $0.030 fallen by 77.78%
$12 Change in substantial holding 27 Jan 2016 11:43AM $0.130 $0.030 fallen by 76.92%
$12 Appendix 3B 22 Jan 2016 6:36PM $0.130 $0.030 fallen by 76.92%
$12 Conversion of Options and Issue of Cleansing Prospectus 22 Jan 2016 6:36PM $0.130 $0.030 fallen by 76.92%
$12 Cleansing Prospectus 22 Jan 2016 6:34PM $0.130 $0.030 fallen by 76.92%
$12 ResApp to Exhibit at Digital Healthcare Conference in Dubai 22 Jan 2016 8:55AM $0.115 $0.030 fallen by 73.91%

501 - 525 of 570 results

Page 21 of 23

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.